EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Nirsevimab immunization's real‐world effectiveness in preventing severe bronchiolitis: A test‐negative case–control study

Marta Agüera iD, Aleix Soler-Garcia iD, Carme Alejandre, Sara Moussalam-Merino, Pere Sala-Castellví iD, Gemma Pons iD, Daniel Penela-Sánchez iD, Carla González-Grado, Judit Alsina-Rossell, Carme Climent, Cristina Esteva iD, Clàudia Fortuny und 8 weitere

Pediatric Allergy and Immunology · 2024

DOI: 10.1111/pai.14175 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Allergy and Immunology, 2024. Verfasst von Marta Agüera und 19 weiteren Autor:innen. Beteiligte Einrichtung: Pediatrics Department, Hospital Sant Joan de Déu, Barcelona, Spain. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Hospitalization. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Several clinical trials have shown that nirsevimab, an antibody targeting the respiratory syncytial virus (RSV), reduces RSV bronchiolitis requiring admission. In 2023–2024, Catalonia and Andorra adopted immunization strategies for children

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsHospitalizationHumansInfantCase-Control StudiesMaleFemaleSpainImmunizationRespiratory Syncytial Virus, HumanBronchiolitisTreatment OutcomeInfant, NewbornSeverity of Illness IndexBronchiolitis, Viral

Stichwörter der Autor:innen

bronchiolitiseffectivenessimmunizationnirsevimabpediatricsseverity

Autor:innen und Institutionen

  • Pediatrics Department, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Pediatric Infectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Déu, Spain.
  • Departament de Cirurgia i Especialitats Medicoquirúrgiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
  • Department of Medicine, School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Pediatrics Department, Hospital General de Catalunya, Barcelona, Spain.
  • Pediatric Intensive Care Unit Department, Hospital Sant Joan de Déu, Barcelona, Spain.

ORCID-Profile: Marta Agüera, Aleix Soler-Garcia, Pere Sala-Castellví, Gemma Pons, Daniel Penela-Sánchez, Cristina Esteva, Mariona-F de-Sevilla, Juan-José García-García, Pedro Brotons, Albert Balaguer, Iolanda Jordan, Carmen Muñoz-Almagro, Cristian Launes

Zitieren

APA

Agüera, M., Soler-Garcia, A., Alejandre, C., Moussalam-Merino, S., Sala-Castellví, P., Pons, G., Penela-Sánchez, D., González-Grado, C., Alsina-Rossell, J., Climent, C., Esteva, C., Fortuny, C., de-Sevilla, M. F., García-García, J. J., Brotons, P., Balaguer, A., Estrada, J., Jordan, I., Muñoz-Almagro, C., & Launes, C. (2024). Nirsevimab immunization's real‐world effectiveness in preventing severe bronchiolitis: A test‐negative case–control study. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.14175

Vancouver

Agüera M, Soler-Garcia A, Alejandre C, Moussalam-Merino S, Sala-Castellví P, Pons G, et al. Nirsevimab immunization's real‐world effectiveness in preventing severe bronchiolitis: A test‐negative case–control study. Pediatric Allergy and Immunology. 2024. doi:10.1111/pai.14175

BibTeX
@article{Agera2024,
  author = {Agüera, Marta and Soler-Garcia, Aleix and Alejandre, Carme and Moussalam-Merino, Sara and Sala-Castellví, Pere and Pons, Gemma and Penela-Sánchez, Daniel and González-Grado, Carla and Alsina-Rossell, Judit and Climent, Carme and Esteva, Cristina and Fortuny, Clàudia and de-Sevilla, Mariona-F and García-García, Juan-José and Brotons, Pedro and Balaguer, Albert and Estrada, Josep and Jordan, Iolanda and Muñoz-Almagro, Carmen and Launes, Cristian},
  title = {Nirsevimab immunization's real‐world effectiveness in preventing severe bronchiolitis: A test‐negative case–control study},
  journal = {Pediatric Allergy and Immunology},
  year = {2024},
  doi = {10.1111/pai.14175}
}
Kostenlos starten →